Inventor · disambiguated record
Satoshi Tsuchiya
Also filed as: TSUCHIYA SATOSHI
12 granted patents·7 pending applications·69 citations·filing 1998–2024
89Inventor score
Top patents by PatentIndex Score
19 records- 0196US10858356B2Pyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Granted Dec 8, 2020·18 cites·17 claims
- 0295US11814381B2Pyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Granted Nov 14, 2023·3 cites·1 claims
- 0394US11420961B2Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2020·Granted Aug 23, 2022·6 cites·19 claims
- 0492US11608347B2Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitorsHOFFMANN LA ROCHE·Filed 2020·Granted Mar 21, 2023·4 cites·30 claims
- 0592US11390610B2Piperazine derivatives as MAGL inhibitorsHOFFMANN LA ROCHE·Filed 2020·Granted Jul 19, 2022·6 cites·38 claims
- 0690US12331050B2Pyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Granted Jun 17, 2025·0 cites·18 claims
- 0789US12331049B2Pyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Granted Jun 17, 2025·0 cites·3 claims
- 0889US2025092041A1Pyrazolopyridine derivative having glp-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0988US12410168B2Pyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Granted Sep 9, 2025·0 cites·11 claims
- 1087US12187724B2Pyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Jan 7, 2025·0 cites·3 claims
- 1171US6346276B1Composition containing useful substances originating in fishes and shellfishes and process for the preparation of the substancesASAHI CHEMICAL IND·Filed 1998·Granted Feb 12, 2002·32 cites·16 claims
- 1270USRE50455EPyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Granted Jun 10, 2025·0 cites·41 claims
- 1370US2023183224A1Bezoxazine derivatives useful as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1468US12365682B2Process to make GLP1 RA and intermediates thereforLILLY CO ELI·Filed 2024·Granted Jul 22, 2025·0 cites·20 claims
- 1566US2023117324A1Oxazine monoacylglycerol lipase (magl) inhibitorsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1660US2024132431A1Method for alkylating acidic functional groupCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1758US2021107920A1Oxazine monoacylglycerol lipase (magl) inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1857US2020308158A1Bezoxazine derivatives useful as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1949US2025154686A1Compound libraryCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Satoshi Tsuchiya files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →